Muted Reaction Could you comment on today's news release? There seems to be strong growth in patient visits and practitioners but is this at the expense of growing revenues and ultimately profits?
The pre release does not have a huge amount of financial details, but is good. Revenue has doubled + from last year and is increasing sequentially. Patient visits are up 50% and moving close to 1M. Free cash flow is growing. Essentially, the company is performing well and its growth plans are on track. The stock had a good jump yesterday, but remains largely ignored by the Street. It puts out regular updates so we are not sure if this one is going to have much of an impact. (5iResearch)